Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F2136C09.svg?ark=w1%2F20260526%2FF2136C09)](https://nobleid.org/work/w1/20260526/F2136C09)

ARK Inflections

Authors & Claims

Paper Authors